Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment
Collaboration focuses on the discovery of novel, non-CRBN/VHL, Targeted Glue™ degraders for oncology and immunology indications Cambridge, UK, 16 July...